Amphista Therapeutics Achieves Breakthrough in Cancer Target Degradation Amphista Therapeutics, a leader in next-generation targeted protein degradation (TPD), has published a study in Nat…
Nokia, Ericsson and Fraunhofer Partnership for NextGen Video Compression Nokia, Ericsson, and Germany's Fraunhofer Heinrich Hertz Institut…
Insurance: Protecting Against AI’s Dark Side Executives face AI-driven cyber threats. Insurers, reinsurers, and corporates are navigating …
Throwback Series: Managing Bilateral Diabetic Macular Edema David Eichenbaum, MD, FASRS, recalls a notable case from early in his practice…
FTSE Mixed as UK Lags Global Rally London stocks opened mixed on Monday, with the FTSE 100 edging up 0.1% to 9,651.66 as the UK market lag…
Guard Therapeutics Announces Top-Line Results from Phase 2b POINTER Study Guard Therapeutics (publ) announced top-line results from the Ph…
AGRITECHNICA: Fraunhofer Presents Innovations for the Agriculture of Tomorrow Climate change, resource scarcity, and growing sustainabilit…
Swift Solar Deploys Perovskite Modules at DoD Cyber Exercise Swift Solar, a US solar technology company, has deployed perovskite solar tec…
Evaxion Appoints New CEO Evaxion A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has appointed Dr. Helen Tayton-Martin as its new Ch…
Trump's Tariffs: Any Road to Relief? Donald Trump has a longstanding fixation with tariffs, once calling them the "greatest thing ever". T…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…